Severely ill COVID-19 patients may need multiple medications delivered by infusion pumps. Manufacturers and hospitals are planning on how to avoid shortages of these pumps and the associated tubing.
You’ve likely seen the videos of ICU hallways lined with medical devices that would normally be in patient rooms.
Among them are machines that are ubiquitous throughout any hospital — “smart” infusion pumps that are programmed to deliver controlled doses of medication. The effects of COVID-19 on patients’ organs heighten the need for these pumps — made by companies including Becton Dickinson (NYSE:BDX), B. Braun, Baxter (NYSE:BAX), ICU Medical (NSDQ:ICUI) and Ivenix.